UC Davis stem cell researcher Paul Knoepfler, right, talks with graduate student Benjamin Yuen in this photo from 2013. Knoepfler is urging federal regulators to finalize guidelines for stem-cell therapies performed on patients and to send notices to clinics offering unproven treatments.
UC Davis stem cell researcher Paul Knoepfler, right, talks with graduate student Benjamin Yuen in this photo from 2013. Knoepfler is urging federal regulators to finalize guidelines for stem-cell therapies performed on patients and to send notices to clinics offering unproven treatments. Renée C. Byer Sacramento Bee file
UC Davis stem cell researcher Paul Knoepfler, right, talks with graduate student Benjamin Yuen in this photo from 2013. Knoepfler is urging federal regulators to finalize guidelines for stem-cell therapies performed on patients and to send notices to clinics offering unproven treatments. Renée C. Byer Sacramento Bee file

Health & Medicine

December 24, 2016 4:00 AM

UC Davis professor wants FDA to create firm guidelines for stem-cell treatments, put clinics on notice

Comments

Videos